People: Kiwa Bio-Tech Products Group Corp (KWBT.PK)

KWBT.PK on OTC Markets Group

0.00USD
23 Apr 2015
Change (% chg)

-- (--)
Prev Close
$0.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
336,317
52-wk High
$0.00
52-wk Low
$0.00

Search Stocks

Summary

Name Age Since Current Position

Wei Li

52 2009 Chairman of the Board, Chief Executive Officer

Ning Ma

56 2009 Chief Financial Officer, Chief Operating Officer

Qi Wang

46 2007 Vice President - Technical, Director

Yvonne Wang

34 2005 Corporate Secretary

Lianjun Luo

43 2008 Director

Xucheng Hu

50 2008 Independent Director

Xin Ma

37 2010 Associate Chief Financial Officer

Biographies

Name Description

Wei Li

Mr. Wei Li is Chairman of the Board, Chief Executive Officer of Kiwa Bio-Tech Products Group Corporation. Prior to the Tintic/Kiwa share exchange transaction, Mr. Li was the acting Chief Executive Officer of Kiwa BVI since January 1, 2004. Mr. Li founded Kiwa BVI to capitalize on the growth of the ag-biotechnology industry in China. Prior to founding Kiwa BVI, Mr. Li founded China Star Investment Group (“China Star”), an entity which provides integrated financing services and/or venture investments to growth businesses in China. Mr. Li served as President of China Star from June 1993 to January 2004. In 1989, Mr. Li founded Xinhua International Market Development Ltd., a company which engaged in investing in China’s high tech, pharmaceutical, medical device, media, entertainment and real estate industries. Mr. Li holds a Bachelor of Science degree in finance from Hunan Finance and Economics University.

Ning Ma

Mr. Steven Ning Ma is Chief Financial Officer, Chief Operating Officer of Kiwa Bio-Tech Products Group Corporation. Prior to joining the Company, Mr. Ma served as Managing Director of SAS Conserve de Provence from 2006 to 2008. Prior to that, Mr. Ma was the Senior Managing Partner of HJV (Hejun) Consulting (Ltd.) from 2004 to 2005. Mr. Ma received his Master degree in Economics/Finance from the Graduate School of Chinese Academy of Sciences. He is also a Ph.D. Candidate in Financial Economics from Wageningen University, Netherlands.

Qi Wang

Professor Qi Wang is Vice President - Technical, Director of Kiwa Bio-Tech Products Group Corporation. Mr. Wang has been a director of Kiwa-CAU R&D Center since July 2006. Mr. Wang served as a Professor and Advisor for Ph.D. students in the Department of Plant Pathology, China Agricultural University (“CAU”) since January 2005. Prior to that, he served as an assistant professor and lecturer of CAU since June 1997. He obtained his masters degree and Ph.D. in agricultural science from CAU in July 1994 and July 1997, respectively. Mr. Wang received his bachelor’s degree of science from Inner Mongolia Agricultural University in July 1989. He is a committee member of various scientific institutes in China, including the National Research and Application Center for Increasing-Yield Bacteria, Chinese Society of Plant Pathology, Chinese Association of Animal Science and Veterinary Medicine.

Yvonne Wang

Ms. Yvonne Wang is Corporate Secretary of Kiwa Bio-Tech Products Group Corporation. Prior to that, she served as an executive assistant and a manager of the Company’s U.S. office between April 2003 and September 2005. She obtained her B.S. degree of Business Administration in July 2001 from University of Phoenix. She is also a California Realtor, and a certified Notary Public.

Lianjun Luo

Mr. Lianjun Luo is Director of Kiwa Bio-Tech Products Group Corporation. From January 2009 to present, Mr. Luo is a Partner of Beijing Pucheng Law Office. Mr. Luo severed as Chief Financial Officer of the Company from March 12, 2004 to December 31, 2008. Mr. Luo served as the Chief Financial Officer of Kiwa BVI from October 2002 to March 2004. From January 2002 to October 2002, Mr. Luo served as the Chief Financial Officer of China Star. From August 2000 to December 2001, Mr. Luo served as manager of the Security Department and as Assistant to the President at Jilin HengFa Group Ltd., a Chinese drug manufacturing company, responsible for the company’s preparation for an aborted IPO and for merger and acquisition activities. From May 1998 to July 2000, Mr. Luo worked as manager of the Investment Department and Associate General Manager for Hongli Industry Co., Ltd., a Chinese investment company on merger and acquisition transactions. Mr. Luo obtained his law degree from China University of Political Science and Law in 1993. Mr. Luo is a certified public accountant and lawyer in China.

Xucheng Hu

Mr. Xucheng Hu is Independent Director of Kiwa Bio-Tech Products Group Corporation. Mr. Hu has been appointed as Executive Director of New Capital International Investment Limited since August 2003, a listed company on the Hong Kong Stock Exchange. Prior to this engagement, Mr. Hu acted as Executive Director of China Property Development (Holdings) Limited and Asia Director of ING Real Estate. Over the past 10 years, he has been working with the Beijing International Trade Association and the Beijing International Trade Research Institute, during which period his responsibilities included performing financial and economic research and providing professional advice on Beijing municipal government's cross-provincial investments and foreign investments, participating in the decision-making process for granting export rights to Beijing government-owned enterprises, evaluating investment proposals as well as supervising sino-foreign investments in Beijing. Mr. Hu graduated with a bachelor degree in economics from the Beijing Economics College in 1983.

Xin Ma

Mr. Xin Ma was Vice President of Kiwa Bio-Tech Products Group Corporation since January 4, 2009. Prior to that Mr. Ma was Associate Chief Financial Officer in January 2006. Prior to that Mr. Ma served as financial controller of LangChao Group. He obtained his MSc. Degrees of Management and of Finance in 2005 and 2006 respectively from the University of Leicester.

Basic Compensation

Name Fiscal Year Total

Wei Li

72,000

Ning Ma

74,400

Qi Wang

19,449

Yvonne Wang

--

Lianjun Luo

48,000

Xucheng Hu

--

Xin Ma

60,000
As Of  30 Dec 2013

Options Compensation

Name Options Value

Wei Li

0 0

Ning Ma

0 0

Qi Wang

0 0

Yvonne Wang

0 0

Lianjun Luo

0 0

Xucheng Hu

0 0

Xin Ma

0 0
Search Stocks